Global Iliac Stent Market Projected to Surpass $1.43 Billion by 2029 with 6.9% Annual Growth

What industry-specific factors are fueling the growth of the iliac stent market?
The rise in the prevalence of peripheral artery diseases is anticipated to drive the growth of the iliac stent market. Peripheral artery disease (PAD) is a circulatory disorder where arteries outside the heart and brain become narrowed or blocked. Contributing factors to PAD include smoking, an aging population, hypertension, and diabetes. Iliac stenting is a highly effective treatment for PAD, improving blood circulation, alleviating symptoms, and preventing complications with minimal invasiveness and high success rates. For example, in July 2023, the Society For Cardiovascular Angiography And Interventions reported that PAD impacts 8-10 million Americans annually, with projections suggesting 19 million Americans will be affected by 2050. This increasing prevalence is propelling the iliac stent market.

Get Your Iliac Stent Market Report Here:
https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

What Is the projected market size and growth rate for the iliac stent market?
The iliac stent market will grow from $1.02 billion in 2024 to $1.09 billion in 2025 at a CAGR of 7.2%, supported by increased awareness of minimally invasive procedures and a rising incidence of iliac artery diseases.

The iliac stent market is projected to reach $1.43 billion by 2029, growing at a CAGR of 6.9%. Growth factors include a rising prevalence of peripheral artery diseases, an aging population, increasing angioplasty procedures, a shift toward minimally invasive surgeries, and a higher incidence of diabetes. Key trends involve technological advancements, expanding distribution networks, product approvals, and the adoption of iliac stents in outpatient settings.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp

What new trends are reshaping the iliac stent market and its opportunities?
Companies in the iliac stent market are introducing innovative products like the iCast-covered stent system to improve patient outcomes and reduce complications. In October 2023, Getinge announced the availability of the iCast-covered stent system in the US. This stent system, approved by the FDA, is used for treating iliac arterial occlusive disease, offering better performance and fewer complications than traditional stents.

What major market segments define the scope and growth of the iliac stent market?
The iliac stent market covered in this report is segmented -

1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types
2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions
3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users

Subsegments:
1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents
3) By Other Types: Covered Stents, Hybrid Stents

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15827

Which region dominates the iliac stent market?
North America was the largest region in the iliac stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the iliac stent industry growth?
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, dic*kinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15827&type=smp

What Is Covered In The Iliac Stent Global Market Report?

•Market Size Forecast: Examine the iliac stent market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the iliac stent market for a structured understanding.
•Key Players Overview: Analyze major players in the iliac stent market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the iliac stent market.
•Segment Contributions: Evaluate how different segments drive overall growth in the iliac stent market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the iliac stent market.
•Industry Challenges: Identify potential risks and obstacles affecting the iliac stent market.
•Competitive Landscape: Review strategic developments in the iliac stent market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.